SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: Bob Richmann who wrote (935)6/5/2000 5:56:00 PM
From: Bosco  Respond to of 1298
 
<edited>Hi all - the biotech sector is very strong today

finance.yahoo.com

and it looks like it broke out of the resistance

finance.yahoo.com

Considering CEGE is a double play [of CEGE and ABGX,] if it is true that the biotech [1st to cave] is one of the sectors leading the rebound, it can be very interesting. Good lord, I'd better tone it down, I sound like a hypster :)

<edited: I am using BBH as a proxy, which is not a true reperesntation of the sector and CEGE may not be part of it, but trend wise, IMHO, it is close>

best, Bosco



To: Bob Richmann who wrote (935)6/6/2000 6:08:00 AM
From: jlib  Read Replies (1) | Respond to of 1298
 
The news is very good (basically a reiteration with monkeys of the lab animal results from March). They are way behind Avigen as far as starting human clinical trials, though. And, as you mentioned, so much hot money jumped in at the close due to the Kernan effect that there will be a lot of volatility today. Should be interesting.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News